Sectoral Asset Management as of March 31, 2017
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 65 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merck & Co (MRK) | 5.3 | $46M | 721k | 63.54 | |
| Johnson & Johnson (JNJ) | 5.0 | $43M | 342k | 124.55 | |
| Pfizer (PFE) | 4.6 | $39M | 1.1M | 34.21 | |
| Neurocrine Biosciences (NBIX) | 4.3 | $37M | 851k | 43.30 | |
| Novartis (NVS) | 4.1 | $35M | 472k | 74.27 | |
| Celgene Corporation | 4.0 | $34M | 272k | 124.43 | |
| Abiomed | 3.8 | $33M | 262k | 125.20 | |
| Amicus Therapeutics (FOLD) | 3.6 | $31M | 4.3M | 7.13 | |
| Dex (DXCM) | 3.5 | $30M | 357k | 84.73 | |
| Shire | 3.5 | $30M | 174k | 174.23 | |
| Acadia Healthcare (ACHC) | 3.5 | $30M | 691k | 43.60 | |
| NuVasive | 3.4 | $29M | 392k | 74.68 | |
| BioMarin Pharmaceutical (BMRN) | 3.2 | $28M | 315k | 87.78 | |
| Teladoc (TDOC) | 3.1 | $27M | 1.1M | 25.00 | |
| Teva Pharmaceutical Industries (TEVA) | 2.8 | $24M | 754k | 32.09 | |
| Mylan Nv | 2.8 | $24M | 611k | 38.99 | |
| Portola Pharmaceuticals | 2.8 | $24M | 604k | 39.19 | |
| ACADIA Pharmaceuticals (ACAD) | 2.7 | $23M | 671k | 34.38 | |
| Intuitive Surgical (ISRG) | 2.6 | $22M | 29k | 766.46 | |
| Edwards Lifesciences (EW) | 2.2 | $19M | 201k | 94.07 | |
| Wright Medical Group Nv | 2.1 | $18M | 581k | 31.12 | |
| Aerie Pharmaceuticals | 2.1 | $18M | 389k | 45.35 | |
| K2m Group Holdings | 2.0 | $17M | 837k | 20.51 | |
| Alder Biopharmaceuticals | 1.7 | $15M | 713k | 20.80 | |
| NxStage Medical | 1.6 | $14M | 505k | 26.83 | |
| Neuroderm Ltd F | 1.5 | $13M | 489k | 26.55 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 1.5 | $13M | 1.3M | 10.06 | |
| Global Blood Therapeutics In | 1.5 | $13M | 346k | 36.85 | |
| Accuray Incorporated (ARAY) | 1.4 | $12M | 2.5M | 4.75 | |
| Integra LifeSciences Holdings (IART) | 1.0 | $8.5M | 203k | 42.13 | |
| Endo International (ENDPQ) | 0.9 | $8.1M | 730k | 11.16 | |
| Prothena (PRTA) | 0.9 | $7.9M | 141k | 55.79 | |
| Envision Healthcare | 0.9 | $7.7M | 125k | 61.32 | |
| Novo Nordisk A/S (NVO) | 0.9 | $7.5M | 218k | 34.28 | |
| Advaxis | 0.8 | $6.9M | 840k | 8.17 | |
| Momenta Pharmaceuticals | 0.7 | $6.1M | 460k | 13.35 | |
| Masimo Corporation (MASI) | 0.6 | $5.0M | 53k | 93.26 | |
| Kite Pharma | 0.6 | $5.0M | 64k | 78.49 | |
| Ra Pharmaceuticals | 0.6 | $4.8M | 225k | 21.29 | |
| Dbv Technologies S A (DBVT) | 0.6 | $4.7M | 134k | 35.22 | |
| Loxo Oncology | 0.4 | $3.8M | 90k | 42.08 | |
| Molina Healthcare (MOH) | 0.4 | $3.7M | 82k | 45.60 | |
| Ptc Therapeutics I (PTCT) | 0.4 | $3.5M | 351k | 9.84 | |
| Acceleron Pharma | 0.4 | $3.3M | 126k | 26.47 | |
| Biogen Idec (BIIB) | 0.4 | $3.2M | 12k | 273.42 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $3.0M | 51k | 58.40 | |
| Intersect Ent | 0.3 | $2.5M | 143k | 17.15 | |
| Incyte Corporation (INCY) | 0.3 | $2.3M | 17k | 133.68 | |
| La Jolla Pharmaceuticl Com Par | 0.3 | $2.3M | 79k | 29.85 | |
| Regeneron Pharmaceuticals (REGN) | 0.3 | $2.2M | 5.7k | 387.53 | |
| Illumina (ILMN) | 0.2 | $1.9M | 11k | 170.66 | |
| Insmed (INSM) | 0.2 | $1.9M | 111k | 17.51 | |
| Tg Therapeutics (TGTX) | 0.2 | $1.6M | 138k | 11.65 | |
| Corvus Pharmaceuticals (CRVS) | 0.2 | $1.4M | 67k | 20.77 | |
| Dr. Reddy's Laboratories (RDY) | 0.1 | $1.3M | 32k | 40.15 | |
| Alnylam Pharmaceuticals (ALNY) | 0.1 | $1.3M | 25k | 51.25 | |
| Avexis | 0.1 | $1.1M | 15k | 76.05 | |
| Celldex Therapeutics | 0.1 | $914k | 253k | 3.61 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $852k | 29k | 29.58 | |
| Sage Therapeutics (SAGE) | 0.1 | $867k | 12k | 71.07 | |
| Trillium Therapeutics, Inc. Cmn | 0.1 | $789k | 128k | 6.15 | |
| Obseva Sa | 0.1 | $786k | 76k | 10.41 | |
| Albireo Pharma | 0.1 | $485k | 20k | 23.98 | |
| Profound Medical | 0.1 | $387k | 496k | 0.78 | |
| Sierra Oncology | 0.0 | $309k | 202k | 1.53 |
